NIH Research Matters

Middle-aged woman holds the back of her left hand to her forehead.
News

Antiviral drug did not improve Long COVID symptoms

A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
X-ray of the human lung.
News

tRNA treatment may help restore cystic fibrosis proteins

Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
Medical illustration of Clostridioides difficile bacteria
News

Bacterial infection may alter developing gut

C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.

 

Displaying 890 - 896 of 912

Intermittent dietary restriction may boost physical endurance

Mice fed a standard diet but deprived of food every other day developed more efficient energy metabolism and improved running endurance. The findings pave the way for studies in people.

Bystanders save lives using defibrillator for cardiac arrest

A study found that people are more likely to survive a cardiac arrest if a bystander uses a defibrillator while waiting for emergency medical services to arrive.

Molecule halts herpes of the eye

A small molecule prevents herpes simplex-1 virus from making viral proteins. The finding suggests a new class of molecule that may be useful for developing antiviral treatments.

Mental disorders may share molecular origins

Patterns of gene expression in the brains of people with five major mental disorders suggest some overlapping mechanisms.

Biological factors and weight loss methods

Researchers found that certain biological differences didn’t predict whether someone would lose more weight from a low-fat or low-carbohydrate diet.

Compound repairs features of Alzheimer's disease in mice

Researchers found that a compound called an NAD+ precursor helped mice with features of Alzheimer's disease perform better on learning and memory tests.

Injection prompts mouse immune system to destroy tumors

Scientists found agents that, when injected into a tumor, direct the mouse immune system to destroy tumors of the same type throughout their bodies. The approach might be applied to many forms of cancer.